Reorganization of Transform Medical's 2 Medical Business Divisions
First written in FY2019. 4 of 5 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「The Olympus Group previously had 2 reporting segments, the endoscopy business and the therapeutic solutions business. To operate more efficiently and with a greater focus on patients and customers, the Group implemented an organizational restructuring, including the reorganization of its business divisions, and changed its reporting segments from the current interim consolidated fiscal period to 2 segments: the Gastrointestinal Endoscopy Solutions business and the Surgical Interventions business.」
Following the organizational restructuring, including the reorganization of the business divisions effective 1 April 2025, the previous 2 segments, endoscopy and therapeutic solutions, were changed to 2 segments: Gastrointestinal Endoscopy Solutions and Surgical Interventions. - FY2025AdvancedAnnual report
「In April 2025, the Company reorganized its endoscopy and therapeutic solutions divisions into the Gastrointestinal Endoscopy Solutions business (GIS) and the Surgical Interventions business (SIS).」
For the fiscal year ending March 2026, the previous 2 divisions, endoscopy and therapeutic solutions, were reorganized into GIS and SIS, transitioning to a structure aimed at patient- and customer-centric operations. - FY2022-Q1AdvancedAnnual report
「Beginning in the first quarter of the current consolidated fiscal year, bronchoscopes, which had previously been included in the endoscopy business segment, were transferred to the therapeutic solutions business segment to strengthen the respiratory field.」
Under the 2-division structure created by Transform Medical, bronchoscopes were transferred from the endoscopy business to the therapeutic solutions business to strengthen the respiratory field. - FY2020-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, the healthcare business was reorganized, and from the current fiscal year its results have been reported separately as the endoscopy business and the therapeutic solutions business.」
Beginning in FY2020-Q1, the healthcare business was divided into the endoscopy business and the therapeutic solutions business, and results reporting began under 5 reporting segments. - FY2019First statedAnnual report
「The Company reorganized its healthcare business from the previous 5 divisions, including the gastroenterology and respiratory business, surgical business, urology and gynecology business, and medical services business, into 2 divisions: the endoscopy business and the therapeutic solutions business.」
The healthcare business was reorganized from the previous 5 divisions into 2 divisions: the endoscopy business and the therapeutic solutions business.